Antibiotic Developments https://www.epmmagazine.com/antibiotic-developments/index.rss The latest pharmaceutical manufacturing news and developments on antibiotics development, antibiotics resistance, antimicrobial resistance, and drug resistance throughout pharmaceutical industries and the pharma manufacturing supply chain en-gb © Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Mon, 07 Jun 2021 10:16:59 -0000 BioVersys receives funding to develop new class of antibiotics to treat multidrug-resistant bacterial infections Switzerland-based pharmaceutical company BioVersys has been awarded up to $4.35 million in funding to develop a new class of antibiotics for its work in developing a new class of antibiotics. https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/bioversys-receives-funding-to-develop/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/bioversys-receives-funding-to-develop/ Mon, 07 Jun 2021 10:16:59 -0000 Antibiotics Current pipeline for antibiotics insufficient in tackling drug resistance The current pipeline for antibiotics is insufficient in addressing drug resistance in the world’s most dangerous bacteria, a new report by the World Health Organisation has revealed. https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/current-pipeline-for-antibiotics-insufficient-in-tackling-dr/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/current-pipeline-for-antibiotics-insufficient-in-tackling-dr/ Wed, 21 Apr 2021 15:10:00 -0000 Drug Resistance Antibiotic Research UK launches £200K grants programme Antibiotic Research UK (ANTRUK) has launched a small research grants programme worth up to £200,000, for researchers working on projects tackling antibiotic resistance. https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/uk/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/uk/ Wed, 14 Apr 2021 12:50:00 -0000 Antibiotics Novo Holdings launches new funding round for AMR projects The next proposal round of the Novo Holdings REPAIR Impact Fund is now open for life science companies developing new treatments to combat antimicrobial resistance (AMR). https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/novo-holdings/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/novo-holdings/ Mon, 29 Mar 2021 09:45:00 -0000 Funding New framework released for responsible use of antibiotic treatments A framework has been released so that treatments targeting antibiotic-resistant bacteria are used responsibly and that the spread of antibiotic-resistant bacteria is minimised when new products are launched onto the market. https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/new-framework-released-for-responsible-use-of-antibiotics/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/new-framework-released-for-responsible-use-of-antibiotics/ Tue, 23 Mar 2021 16:20:00 -0000 Antibiotics GSK to receive CARB-X funding to develop superbug vaccines GSK is to receive $18 million in funding for the development of new vaccines that can prevent serious infections caused by two different pathogens. https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/gsk-to-receive-carb-x-funding-to/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/gsk-to-receive-carb-x-funding-to/ Mon, 01 Mar 2021 15:20:00 -0000 AMR Australian project to revitalise antibiotics receives funding from CARB-X The University of Queensland (UQ) for Molecular Bioscience (IMB) has been given $2.2 million in funding from CARB-X to expand research for a new drug designed use in low- and middle-income countries (LMICs) where there are high levels of drug-resista https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/australian-project-to-revitalise-antibiotics-receives-fundin/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/australian-project-to-revitalise-antibiotics-receives-fundin/ Thu, 25 Feb 2021 10:15:00 -0000 Antibiotics Biopharma awarded $6.4m for drug that fights 'nightmare bacteria' French biopharmaceutical firm Mutabilis has been awarded $6.4 million to develop a new drug to treat infections caused by Carbapenem-resistant Enterobacterales (CRE) bacteria. https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/biopharma-awarded-6-4m-to-fight-nightmar/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/biopharma-awarded-6-4m-to-fight-nightmar/ Wed, 03 Feb 2021 09:30:00 -0000 Bacteria Device to determine most effective antibiotic receives funding CARB-X is funding Avails Medical to develop an electronic antibiotic susceptibility testing device to speed up health care providers’ ability to determine the most effective antibiotic treatment for serious and life-threatening blood infections. https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/device-to-determine-determine-effective-antibiotics-receives/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/device-to-determine-determine-effective-antibiotics-receives/ Tue, 02 Feb 2021 10:10:00 -0000 Antibiotics Scottish pharmacy teams up with medtech company to help reduce antibiotic resistance A community pharmacy in Inverness has entered into a partnership with a medtech company to help tackle antibiotic resistance in healthcare. https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/scottish-pharmacy-teams-up-with-medtech-company-to-help-redu/ https://www.epmmagazine.com/pharma-manufacturing-news/antibiotic-developments/scottish-pharmacy-teams-up-with-medtech-company-to-help-redu/ Wed, 13 Jan 2021 09:55:00 -0000 Antibiotics